Rawan Awad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rawan Awad has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Andreu F. Costa
Department of Diagnostic Radiology Queen Elizabeth II Health Sciences Centre and Dalhousie University Halifax Nova Scotia Canada
3 shared publications - Christian B. van der Pol
McMaster University Hamilton Ontario Canada
3 shared publications - Eric Lam
Ottawa Hospital Research Institute, ON, Canada
3 shared publications - Mostafa Alabousi
University of Toronto
3 shared publications - Brooke Levis
Department of Epidemiology Biostatistics and Occupational Health, McGill University Montréal Québec Canada
2 shared publications - Christopher Clarke
Department of Radiology Nottingham University Hospitals NHS Trust Nottingham UK
2 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
Simplifying CT / MRI LI ‐ RADS v2018 Maintains Diagnostic Performance: An Individual Participant Data Meta‐Analysis
Background: The Liver Imaging Reporting and Data System (LI‐RADS) diagnostic algorithm assesses hepatocellular carcinoma (HCC) probability of liver observations in high‐risk individuals, but complexity may limit its adoption. Purpose: To evaluate whether LI‐RADS v2018 can be simplified without impairing diagnostic performance by removing threshold growth (TG) and reducing size cut‐offs. Study Type: Retrospective meta‐analysis. Population: Eight thousand five hundred eighty‐two patients (mean age: 59 ± 11 years; 6610 male) at risk for HCC with CT/MRI (986 CT, 6554 MRI, and 1042 CT/MRI). Field Strength/Sequence: Field strength: 1.5T and 3.0T; sequences varied by institution per LI‐RADS technical requirements. Assessment: LI‐RADS v2018 using major features only was compared with seven simplifications removing TG and/or applying single size cut‐offs (≥ 10, ≥ 15, and ≥ 20 mm) in individual participant data (IPD) of 64 studies (29 institutions, 11 countries) from the LI‐RADS Living Systematic Review and IPD Meta‐analysis Project. Risk of bias was assessed with QUADAS‐2. Statistical Tests: Summary receiver operating characteristic curves estimated area under the curve (AUC) across LR‐3 to LR‐5; LR‐5 sensitivity, specificity, and positive predictive value (PPV) were estimated using a one‐step bivariate mixed‐effects model. Differences were assessed by cluster bootstrap. p < 0.05 indicated significance, uncorrected for multiple comparisons. Results: Nine thousand four hundred six observations were included. Excluding TG with a 10‐mm cut‐off showed AUC similar to LI‐RADS v2018 (0.80 vs. 0.81, p = 0.44) and significantly higher LR‐5 sensitivity (73.8% vs. 71.8%) with similar specificity (72.5% vs. 73.7%, p = 0.13) and PPV (97.8% vs. 97.8%, p = 0.73). Removing TG with 15‐mm and 20‐mm cut‐offs had significantly lower AUC than v2018 (−0.03 [95% CI: −0.041, −0.019]; −0.043 [−0.054, −0.032], respectively) and sensitivity (−13.2% [95% CI: −14.5%, −12.0%]; −30.1% [−31.7%, −28.5%], respectively). Of the 64 studies, 17 had low‐risk of bias, and 56 had low applicability concerns. Conclusion: Simplifying LI‐RADS v2018 by removing TG and using a 10‐mm size cut‐off preserved diagnostic table AUC while improving LR‐5 sensitivity without loss of specificity or PPV. Protocol Registration: Open Science Framework ( https://osf.io/cjwgp ). Evidence Level: 3. Technical Efficiency: Stage 2.
- 2 November 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
Open AccessSimplifying CT / MRI LI ‐ RADS v2018 Maintains Diagnostic Performance: An Individual Participant Data Meta‐Analysis
Background: The Liver Imaging Reporting and Data System (LI‐RADS) diagnostic algorithm assesses hepatocellular carcinoma (HCC) probability of liver observations in high‐risk individuals, but complexity may limit its adoption. Purpose: To evaluate whether LI‐RADS v2018 can be simplified without impairing diagnostic performance by removing threshold growth (TG) and reducing size cut‐offs. Study Type: Retrospective meta‐analysis. Population: Eight thousand five hundred eighty‐two patients (mean age: 59 ± 11 years; 6610 male) at risk for HCC with CT/MRI (986 CT, 6554 MRI, and 1042 CT/MRI). Field Strength/Sequence: Field strength: 1.5T and 3.0T; sequences varied by institution per LI‐RADS technical requirements. Assessment: LI‐RADS v2018 using major features only was compared with seven simplifications removing TG and/or applying single size cut‐offs (≥ 10, ≥ 15, and ≥ 20 mm) in individual participant data (IPD) of 64 studies (29 institutions, 11 countries) from the LI‐RADS Living Systematic Review and IPD Meta‐analysis Project. Risk of bias was assessed with QUADAS‐2. Statistical Tests: Summary receiver operating characteristic curves estimated area under the curve (AUC) across LR‐3 to LR‐5; LR‐5 sensitivity, specificity, and positive predictive value (PPV) were estimated using a one‐step bivariate mixed‐effects model. Differences were assessed by cluster bootstrap. p < 0.05 indicated significance, uncorrected for multiple comparisons. Results: Nine thousand four hundred six observations were included. Excluding TG with a 10‐mm cut‐off showed AUC similar to LI‐RADS v2018 (0.80 vs. 0.81, p = 0.44) and significantly higher LR‐5 sensitivity (73.8% vs. 71.8%) with similar specificity (72.5% vs. 73.7%, p = 0.13) and PPV (97.8% vs. 97.8%, p = 0.73). Removing TG with 15‐mm and 20‐mm cut‐offs had significantly lower AUC than v2018 (−0.03 [95% CI: −0.041, −0.019]; −0.043 [−0.054, −0.032], respectively) and sensitivity (−13.2% [95% CI: −14.5%, −12.0%]; −30.1% [−31.7%, −28.5%], respectively). Of the 64 studies, 17 had low‐risk of bias, and 56 had low applicability concerns. Conclusion: Simplifying LI‐RADS v2018 by removing TG and using a 10‐mm size cut‐off preserved diagnostic table AUC while improving LR‐5 sensitivity without loss of specificity or PPV. Protocol Registration: Open Science Framework ( https://osf.io/cjwgp ). Evidence Level: 3. Technical Efficiency: Stage 2.
- Open Access
- 7 August 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
Inter‐Reader Agreement for CT and MRI LI ‐ RADS Version 2018: An Individual Participant Data Meta‐Analysis
Background: The Liver Imaging Reporting and Data System (LI‐RADS) is a classification system to diagnose hepatocellular carcinoma (HCC) noninvasively. The reported LI‐RADS inter‐reader variability in single‐center studies highlights the need to better understand the variability on a broader scale. Purpose: Evaluate inter‐reader agreement for LI‐RADS CT/MRI v2018 categorization and imaging features using individual participant data (IPD) meta‐analysis for MRI and CT separately. Study Type: Retrospective meta‐analysis. Population: 805 patients (542 male, mean age 60.8 ± 11.6 [SD] years) at risk of HCC. Field Strength/Sequence: 1.5 and 3 T, Sequences varied across institutions but followed standard LI‐RADS protocols. Assessment: Studies from the LI‐RADS Living IPD Meta‐Analysis Project were used. Inclusion criteria: observations evaluated by > 1 reader using LI‐RADS CT/MRI v2018. Risk of bias was assessed for the index test domain using QUADAS‐2; sensitivity analysis was conducted excluding high‐risk observations. The developed protocol is available on the Open Science Framework ( https://osf.io/tdv7j/files/6kh7s ). Statistical Tests: A two‐step meta‐analytic approach was used to determine pooled kappa ( κ ) with heterogeneity assessed using τ 2 and I 2 . A post hoc univariable meta regression was conducted using the following variables: number of readers, reader experience, feature prevalence, and study country. Statistical significance was defined as two‐tailed p < 0.05. Results: Five studies (three CT and MRI, two MRI) comprising 975 observations were included. Four studies had two readers, and one had three, most readers were specialized abdominal radiologists (3–33 years' experience). Inter‐reader agreement ( κ ) for major features was 0.21–0.74 on MRI and 0.11–0.75 on CT. For Ancillary features, κ was −0.02 to 0.68 for MRI and −0.02 to 0.58 on CT, and LR‐M agreement was −0.07 to 0.58 on MRI and −0.07 to 0.66 on CT. LI‐RADS categorization showed agreement of κ = 0.76 for MRI and κ = 0.50 for CT. Data Conclusion: MRI consistently reported higher agreement than CT for shared features, but overall inter‐reader agreement was variable. Evidence Level: 3. Technical Efficacy: Stage 2: diagnostic accuracy, considered by most as clinical efficacy.
- 7 August 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
Open AccessInter‐Reader Agreement for CT and MRI LI ‐ RADS Version 2018: An Individual Participant Data Meta‐Analysis
Background: The Liver Imaging Reporting and Data System (LI‐RADS) is a classification system to diagnose hepatocellular carcinoma (HCC) noninvasively. The reported LI‐RADS inter‐reader variability in single‐center studies highlights the need to better understand the variability on a broader scale. Purpose: Evaluate inter‐reader agreement for LI‐RADS CT/MRI v2018 categorization and imaging features using individual participant data (IPD) meta‐analysis for MRI and CT separately. Study Type: Retrospective meta‐analysis. Population: 805 patients (542 male, mean age 60.8 ± 11.6 [SD] years) at risk of HCC. Field Strength/Sequence: 1.5 and 3 T, Sequences varied across institutions but followed standard LI‐RADS protocols. Assessment: Studies from the LI‐RADS Living IPD Meta‐Analysis Project were used. Inclusion criteria: observations evaluated by > 1 reader using LI‐RADS CT/MRI v2018. Risk of bias was assessed for the index test domain using QUADAS‐2; sensitivity analysis was conducted excluding high‐risk observations. The developed protocol is available on the Open Science Framework ( https://osf.io/tdv7j/files/6kh7s ). Statistical Tests: A two‐step meta‐analytic approach was used to determine pooled kappa ( κ ) with heterogeneity assessed using τ 2 and I 2 . A post hoc univariable meta regression was conducted using the following variables: number of readers, reader experience, feature prevalence, and study country. Statistical significance was defined as two‐tailed p < 0.05. Results: Five studies (three CT and MRI, two MRI) comprising 975 observations were included. Four studies had two readers, and one had three, most readers were specialized abdominal radiologists (3–33 years' experience). Inter‐reader agreement ( κ ) for major features was 0.21–0.74 on MRI and 0.11–0.75 on CT. For Ancillary features, κ was −0.02 to 0.68 for MRI and −0.02 to 0.58 on CT, and LR‐M agreement was −0.07 to 0.58 on MRI and −0.07 to 0.66 on CT. LI‐RADS categorization showed agreement of κ = 0.76 for MRI and κ = 0.50 for CT. Data Conclusion: MRI consistently reported higher agreement than CT for shared features, but overall inter‐reader agreement was variable. Evidence Level: 3. Technical Efficacy: Stage 2: diagnostic accuracy, considered by most as clinical efficacy.
- Open Access
- 12 April 2026
- Published by SAGE Publications in Canadian Association of Radiologists Journal
- Vol. 77 (4) , 651-660
Geographic and Sex Distribution of LI-RADS Research Globally: A Cross-Sectional Meta-Research Study
Background: Hepatocellular carcinoma (HCC) has an uneven global distribution and a higher incidence in males. The Liver Imaging Reporting and Data System (LI-RADS) is a standardized imaging framework for HCC diagnosis. It is unclear whether the evidence used to inform LI-RADS reflects the global burden of HCC. Purpose: To determine whether the geographic and sex distribution of studies assessing LI-RADS and those included in the LI-RADS individual participant data (IPD) database reflect the global burden of HCC. Materials and Methods: We conducted a cross-sectional meta-research study comparing the country- and sex-specific HCC prevalence from GLOBOCAN 2022 with the distribution of studies eligible for and included in the LI-RADS IPD database. Studies were identified through a systematic search of 4 databases. Study Protocol: OSF page . Results: We identified 470 eligible studies including 98 014 patients; of these, 76 studies comprising 11 924 patients were included in the IPD database. Asian and African countries, excluding Republic of Korea, were underrepresented in both the eligible and the IPD dataset. North America was overrepresented. Female patients were under-represented in LI-RADS eligible studies ( Z = −21.95, P < .0001) and in studies included in the IPD ( Z = −9.02, P < .0001) compared to the global prevalence of HCC in females. Conclusion: LI-RADS research is disproportionately reported from some countries relative to HCC burden. Asia, Africa, and female patients remain underrepresented. This may affect the generalizability and diagnostic equity of the LI-RADS system and underscore the need for improved global inclusivity in LI-RADS research.
- 12 April 2026
- Published by SAGE Publications in Canadian Association of Radiologists Journal
- Vol. 77 (4) , 651-660
Open AccessGeographic and Sex Distribution of LI-RADS Research Globally: A Cross-Sectional Meta-Research Study
Background: Hepatocellular carcinoma (HCC) has an uneven global distribution and a higher incidence in males. The Liver Imaging Reporting and Data System (LI-RADS) is a standardized imaging framework for HCC diagnosis. It is unclear whether the evidence used to inform LI-RADS reflects the global burden of HCC. Purpose: To determine whether the geographic and sex distribution of studies assessing LI-RADS and those included in the LI-RADS individual participant data (IPD) database reflect the global burden of HCC. Materials and Methods: We conducted a cross-sectional meta-research study comparing the country- and sex-specific HCC prevalence from GLOBOCAN 2022 with the distribution of studies eligible for and included in the LI-RADS IPD database. Studies were identified through a systematic search of 4 databases. Study Protocol: OSF page . Results: We identified 470 eligible studies including 98 014 patients; of these, 76 studies comprising 11 924 patients were included in the IPD database. Asian and African countries, excluding Republic of Korea, were underrepresented in both the eligible and the IPD dataset. North America was overrepresented. Female patients were under-represented in LI-RADS eligible studies ( Z = −21.95, P < .0001) and in studies included in the IPD ( Z = −9.02, P < .0001) compared to the global prevalence of HCC in females. Conclusion: LI-RADS research is disproportionately reported from some countries relative to HCC burden. Asia, Africa, and female patients remain underrepresented. This may affect the generalizability and diagnostic equity of the LI-RADS system and underscore the need for improved global inclusivity in LI-RADS research.